All 3 probands were diagnosed before age 15, and had stage 2 hypertension, requiring either a calcium channel blocker (PH10433 and PH10149) or an angiotensin-converting enzyme inhibitor (PH10237) (Figure 1B). This evidence concerns the gene ACE and Hypertension.